Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review.
Martin ZarbaRyo FujiwaraTakeshi YuasaFumitaka KogaDaniel Y C HengKosuke TakemuraPublished in: Expert review of anticancer therapy (2024)
Multimodal cancer therapies are essential for conquering complex cases of mRCC. Modern systemic therapies including IO-based combination therapy as well as local therapies including CN, metastasectomy, stereotactic radiotherapy, and ablative techniques appear to improve oncologic outcomes of patients with mRCC, although appropriate patient selection is indispensable.
Keyphrases
- papillary thyroid
- combination therapy
- metastatic renal cell carcinoma
- early stage
- radiation therapy
- case report
- small cell lung cancer
- type diabetes
- metabolic syndrome
- quality improvement
- radiation induced
- pain management
- skeletal muscle
- radical prostatectomy
- robot assisted
- chronic pain
- insulin resistance
- glycemic control